Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis

Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach. SLE and COVID-19 datasets were extrac...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1179664
Main Authors Zeng, Huiqiong, Zhuang, Yu, Li, Xiaojuan, Yin, Zhihua, Huang, Xia, Peng, Haiyan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.06.2023
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2023.1179664

Cover

Abstract Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach. SLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration. A total of 6 common hub genes ( , and ) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes. Our research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.
AbstractList ObjectiveEvidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach.MethodsSLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in R was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed via utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration.ResultsA total of 6 common hub genes (CDC6, PLCG1, KIF15, LCK, CDC25C, and RASGRP1) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes.ConclusionOur research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.
Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach.ObjectiveEvidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach.SLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in R was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed via utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration.MethodsSLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in R was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed via utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration.A total of 6 common hub genes (CDC6, PLCG1, KIF15, LCK, CDC25C, and RASGRP1) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes.ResultsA total of 6 common hub genes (CDC6, PLCG1, KIF15, LCK, CDC25C, and RASGRP1) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes.Our research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.ConclusionOur research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.
Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach. SLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration. A total of 6 common hub genes ( , and ) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes. Our research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.
Author Yin, Zhihua
Zeng, Huiqiong
Li, Xiaojuan
Huang, Xia
Zhuang, Yu
Peng, Haiyan
AuthorAffiliation 1 Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Futian District , Shenzhen, Guangdong , China
3 Department of Public Health, Shenzhen Hospital of Southern Medical University , Shenzhen , China
2 Department of Rheumatology and Immunology, Huizhou Central People’s Hospital , Huizhou, Guangdong , China
4 Department of Xi Yuan Community Health Service Center, The Eighth Affiliated Hospital of Sun Yat-sen University , Shenzhen, Guangdong , China
AuthorAffiliation_xml – name: 1 Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Futian District , Shenzhen, Guangdong , China
– name: 2 Department of Rheumatology and Immunology, Huizhou Central People’s Hospital , Huizhou, Guangdong , China
– name: 4 Department of Xi Yuan Community Health Service Center, The Eighth Affiliated Hospital of Sun Yat-sen University , Shenzhen, Guangdong , China
– name: 3 Department of Public Health, Shenzhen Hospital of Southern Medical University , Shenzhen , China
Author_xml – sequence: 1
  givenname: Huiqiong
  surname: Zeng
  fullname: Zeng, Huiqiong
– sequence: 2
  givenname: Yu
  surname: Zhuang
  fullname: Zhuang, Yu
– sequence: 3
  givenname: Xiaojuan
  surname: Li
  fullname: Li, Xiaojuan
– sequence: 4
  givenname: Zhihua
  surname: Yin
  fullname: Yin, Zhihua
– sequence: 5
  givenname: Xia
  surname: Huang
  fullname: Huang, Xia
– sequence: 6
  givenname: Haiyan
  surname: Peng
  fullname: Peng, Haiyan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37426642$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_0BVggL9nM4Ftie4XQUMpIlboBtpbHOZm4SuxgO4V5DZ4YT2eKWhZ4c2yf_3zHl_-8OvHBQ1W9IXjJmFTvOzeO85JiypaECNU0_EV1RkpYMEr5yZP5aXWZ0h0ugyvGWP2qOmWC05KmZ9Xvq1_TEKLzW5R7QFPI4LMzA7JhHINHLfgwOm9yiGgyuQ9b8JBcQqFDaZcyjGiYpzkhiLsCGIswldVPl3u0uv2-_rQgCm1MghYVWoFOEXrwyd0D2rjgfBdiKXI2IePNsCvo19XLzgwJLo_xovr2-err6svi5vZ6vfp4s7C8UXnR1kYYACUlJoZKbA3bSNEAxRbbcjtVG0o4tpJYXnPKjbCtqIEx1VEsgLCLan3gtsHc6Sm60cSdDsbph40Qt9rEcrIBtJJYEtHVtsGUK8CqNdJy3sgOC9oqXFgfDqxp3ozQ2vKI0QzPoM8z3vV6G-41wYzWgu0J746EGH7MkLIeXbIwDMZDmJOmkjVUESFkkb592uxvl8dfLQJ5ENgYUorQaetyeeSw7-2G0lTvPaQfPKT3HtJHD5VS-k_pI_0_RX8AjKDORg
CitedBy_id crossref_primary_10_1016_j_vaccine_2024_126484
crossref_primary_10_1016_j_intimp_2024_112048
crossref_primary_10_1177_09612033241309845
Cites_doi 10.1186/s13256-020-02582-8
10.3390/ijms23031716
10.1093/nar/gky311
10.1038/s41579-022-00713-0
10.1016/j.immuni.2018.03.025
10.1186/s12941-021-00438-7
10.1016/j.isci.2021.102711
10.1016/j.intimp.2021.108255
10.1016/j.autrev.2017.11.009
10.1016/j.ijbiomac.2018.12.146
10.3892/mmr.2021.11998
10.1038/nri3403
10.1038/nri3024
10.1080/08916934.2019.1631812
10.1038/s42003-022-04067-4
10.1093/rheumatology/40.2.152
10.1038/s41584-021-00741-9
10.1007/s11684-021-0906-x
10.1016/j.tim.2022.12.008
10.3389/fimmu.2021.683249
10.1136/annrheumdis-2021-221636
10.1101/2020.04.09.20059626
10.1016/j.cell.2018.01.029
10.1038/sj.onc.1205821
10.1136/annrheumdis-2020-218296
10.1016/j.autrev.2020.102524
10.7326/AITC202006020
10.3389/fimmu.2019.01066
10.3390/cells11121978
10.1016/j.beha.2022.101401
10.26355/eurrev_201908_18744
10.1038/s42003-023-04447-4
10.3390/ijms24021652
10.1007/s00296-022-05183-4
10.1016/j.biochi.2020.09.018
10.1126/science.abc8511
10.1007/s10787-022-00992-2
10.1038/s41591-020-0901-9
10.1126/science.abd4585
10.3390/cells9040915
10.3389/fimmu.2020.623944
10.3389/fimmu.2021.695242
10.1038/nature09247
10.1093/nar/gkz240
10.1186/ar2964
10.1038/nrrheum.2016.186
10.1016/j.rdc.2021.04.006
10.1136/annrheumdis-2021-eular.2809
10.1007/s12519-019-00229-3
10.1007/s10067-020-05073-9
10.1016/j.immuni.2016.06.028
10.1016/j.clim.2020.108524
10.1126/scitranslmed.aax1159
10.1007/978-1-4939-9424-3_31
10.1007/s10067-020-05301-2
10.2169/internalmedicine.40.80
10.3899/jrheum.200452
10.2217/fmb-2022-0103
10.1177/0961203308093923
10.1016/j.cell.2018.08.065
10.4049/jimmunol.1100450
10.7150/jca.57334
10.3389/fimmu.2021.789788
10.1093/bioinformatics/btt138
10.1177/0961203314531637
10.1093/bioinformatics/btp311
10.1038/nmeth.2689
10.1172/jci.insight.138999
10.1016/j.jaut.2021.102730
10.1016/j.jaut.2018.10.025
10.1681/ASN.2020060802
ContentType Journal Article
Copyright Copyright © 2023 Zeng, Zhuang, Li, Yin, Huang and Peng.
Copyright © 2023 Zeng, Zhuang, Li, Yin, Huang and Peng 2023 Zeng, Zhuang, Li, Yin, Huang and Peng
Copyright_xml – notice: Copyright © 2023 Zeng, Zhuang, Li, Yin, Huang and Peng.
– notice: Copyright © 2023 Zeng, Zhuang, Li, Yin, Huang and Peng 2023 Zeng, Zhuang, Li, Yin, Huang and Peng
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2023.1179664
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_980817f5c60249e09da8c4468f072d90
PMC10325730
37426642
10_3389_fimmu_2023_1179664
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-d5a7aee98801a280ca3b876e20c0c26695a2140c81c45424a7cd75e339f207e13
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:29:12 EDT 2025
Thu Aug 21 18:37:07 EDT 2025
Thu Sep 04 20:10:12 EDT 2025
Thu Apr 03 07:03:49 EDT 2025
Tue Jul 01 03:33:29 EDT 2025
Thu Apr 24 22:51:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
immune cells infiltration
diagnostic biomarkers
system lupus erythematosus
bioinformatics
Language English
License Copyright © 2023 Zeng, Zhuang, Li, Yin, Huang and Peng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-d5a7aee98801a280ca3b876e20c0c26695a2140c81c45424a7cd75e339f207e13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Meijuan Zhou, Southern Medical University, China
Reviewed by: Pier Maria Fornasari, REGENHEALTHSOLUTIONS, Italy; Yukai Wang, Shantou Central Hospital, China
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2023.1179664
PMID 37426642
PQID 2836291778
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_980817f5c60249e09da8c4468f072d90
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10325730
proquest_miscellaneous_2836291778
pubmed_primary_37426642
crossref_citationtrail_10_3389_fimmu_2023_1179664
crossref_primary_10_3389_fimmu_2023_1179664
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-22
PublicationDateYYYYMMDD 2023-06-22
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-22
  day: 22
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Kiriakidou (B5) 2020; 172
Clottu (B70) 2022; 12
Park (B53) 2023; 6
Zhang (B2) 2022; 16
Chen (B26) 2020; 47
Liao (B61) 2020; 26
Tsokos (B30) 2016; 12
Lotia (B17) 2013; 29
Shah (B71) 2010; 12
Hannawi (B39) 2021; 80
Liu (B16) 2009; 25
Franz (B18) 2018; 46
Yunis (B34) 2023; 31
Han (B48) 2019; 11
Caso (B8) 2020; 19
Griffith (B72) 2013; 10
Mathew (B33) 2020; 369
Canny (B69) 2021; 47
Curran (B46) 2019; 97
Gusev (B60) 2022; 23
Pruchniak (B67) 2019; 52
Rosetti (B42) 2022; 18
Jog (B24) 2021; 3
Hsu (B38) 2023; 24
Sabbatino (B50) 2021; 7
Kudose (B13) 2020; 31
Pablos (B10) 2020; 79
Bastard (B31) 2020; 370
Muralidar (B1) 2020; 179
Fousert (B64) 2020; 9
B3
Brownlie (B54) 2013; 13
Bonam S (B49) 2022; 17
Rada (B63) 2019; 1982
Molineros (B40) 2019; 20
Chasset (B32) 2018; 17
Piccolo (B35) 2002; 21
Niedźwiedzka-Rystwej (B51) 2022; 11
Lamers (B29) 2022; 20
Misra (B9) 2020; 39
Lambert (B19) 2018; 172
Poissonnier (B36) 2016; 45
Hasanvand (B52) 2022; 30
Mallah (B4) 2021; 20
Lee (B45) 2009; 18
Pan (B6) 2020; 16
Santos (B11) 2020; 39
Berry (B15) 2010; 466
Ghosh (B44) 2021; 12
Zamani (B12) 2021; 15
Lévy (B14) 2021; 24
Attiq (B55) 2021; 101
Raiker (B28) 2021; 125
Davitt (B59) 2022; 35
Ugarte-Gil (B27) 2022; 81
Tu (B41) 2018; 48
Villanueva (B68) 2011; 187
Mantovani (B62) 2011; 11
Nelson (B22) 2014; 23
Hsu (B23) 2001; 40
Fu (B57) 2019; 23
Kong (B56) 2019; 15
Sekigawa (B25) 2001; 40
Fatoye (B7) 2022; 42
Zuo (B66) 2020
Zuo (B65) 2020; 5
Coscia (B21) 2018; 175
Zhao (B58) 2021; 23
Zhou (B20) 2019; 47
Lin (B43) 2020; 218
Liang (B47) 2021; 5
Cheshenko (B37) 2022; 5
References_xml – volume: 15
  start-page: 29
  year: 2021
  ident: B12
  article-title: Systemic lupus erythematosus manifestation following COVID-19: a case report
  publication-title: J Med Case Rep
  doi: 10.1186/s13256-020-02582-8
– volume: 23
  year: 2022
  ident: B60
  article-title: SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23031716
– volume: 46
  year: 2018
  ident: B18
  article-title: GeneMANIA update 2018
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gky311
– volume: 20
  year: 2022
  ident: B29
  article-title: SARS-CoV-2 pathogenesis
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-022-00713-0
– ident: B3
– volume: 48
  start-page: 745
  year: 2018
  ident: B41
  article-title: T Cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.03.025
– volume: 20
  start-page: 35
  year: 2021
  ident: B4
  article-title: COVID-19: breaking down a global health crisis
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/s12941-021-00438-7
– volume: 24
  year: 2021
  ident: B14
  article-title: French COVID cohort study group. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
  publication-title: iScience
  doi: 10.1016/j.isci.2021.102711
– volume: 101
  year: 2021
  ident: B55
  article-title: The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.108255
– volume: 17
  start-page: 44
  year: 2018
  ident: B32
  article-title: Targeting interferons and their pathways in systemic lupus erythematosus
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2017.11.009
– volume: 15
  year: 2019
  ident: B56
  article-title: TNF-α regulates microglial activation via the NF-κB signaling pathway in systemic lupus erythematosus with depression
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2018.12.146
– volume: 23
  start-page: 359
  year: 2021
  ident: B58
  article-title: miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-κB pathway
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2021.11998
– volume: 13
  year: 2013
  ident: B54
  article-title: T Cell receptor signalling networks: branched, diversified and bounded
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3403
– volume: 11
  year: 2011
  ident: B62
  article-title: Neutrophils in the activation and regulation of innate and adaptive immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3024
– volume: 52
  year: 2019
  ident: B67
  article-title: Neutrophil extracellular traps generation and degradation in patients with granulomatosis with polyangiitis and systemic lupus erythematosus
  publication-title: Autoimmunity
  doi: 10.1080/08916934.2019.1631812
– volume: 5
  start-page: 1096
  year: 2022
  ident: B37
  article-title: Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2
  publication-title: Commun Biol
  doi: 10.1038/s42003-022-04067-4
– volume: 40
  year: 2001
  ident: B23
  article-title: Human parvovirus B19 infection in patients with systemic lupus erythematosus
  publication-title: Rheumatol (Oxford)
  doi: 10.1093/rheumatology/40.2.152
– volume: 18
  year: 2022
  ident: B42
  article-title: Regulation of activated T cell survival in rheumatic autoimmune diseases
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-021-00741-9
– volume: 16
  year: 2022
  ident: B2
  article-title: SARS-CoV-2 variants, immune escape, and countermeasures
  publication-title: Front Med
  doi: 10.1007/s11684-021-0906-x
– volume: 31
  year: 2023
  ident: B34
  article-title: Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2022.12.008
– volume: 5
  year: 2021
  ident: B47
  article-title: Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands+ macrophages via activating IL-4/STAT6/PD-L2 signaling
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.683249
– volume: 81
  year: 2022
  ident: B27
  article-title: Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology alliance
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2021-221636
– year: 2020
  ident: B66
  article-title: Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19
  publication-title: medRxiv
  doi: 10.1101/2020.04.09.20059626
– volume: 172
  year: 2018
  ident: B19
  article-title: The human transcription factors
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.029
– volume: 21
  year: 2002
  ident: B35
  article-title: The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1205821
– volume: 79
  year: 2020
  ident: B10
  article-title: Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-218296
– volume: 19
  year: 2020
  ident: B8
  article-title: Could sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2020.102524
– volume: 172
  year: 2020
  ident: B5
  article-title: Systemic lupus erythematosus
  publication-title: Ann Intern Med
  doi: 10.7326/AITC202006020
– volume: 20
  year: 2019
  ident: B40
  article-title: Mechanistic characterization of RASGRP1 variants identifies an hnRNP-K-Regulated transcriptional enhancer contributing to SLE susceptibility
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01066
– volume: 11
  year: 2022
  ident: B51
  article-title: Programmed cell death-1/Programmed cell death-1 ligand as prognostic markers of coronavirus disease 2019 severity
  publication-title: Cells
  doi: 10.3390/cells11121978
– volume: 35
  year: 2022
  ident: B59
  article-title: COVID-19 disease and immune dysregulation
  publication-title: Best Pract Res Clin Haematol
  doi: 10.1016/j.beha.2022.101401
– volume: 23
  year: 2019
  ident: B57
  article-title: MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-κB pathway
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201908_18744
– volume: 6
  start-page: 76
  year: 2023
  ident: B53
  article-title: Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity
  publication-title: Commun Biol
  doi: 10.1038/s42003-023-04447-4
– volume: 24
  year: 2023
  ident: B38
  article-title: A focused review of ras guanine nucleotide-releasing protein 1 in immune cells and cancer
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24021652
– volume: 42
  year: 2022
  ident: B7
  article-title: Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-022-05183-4
– volume: 179
  start-page: 85
  year: 2020
  ident: B1
  article-title: The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2020.09.018
– volume: 369
  year: 2020
  ident: B33
  article-title: Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
  publication-title: Science
  doi: 10.1126/science.abc8511
– volume: 30
  year: 2022
  ident: B52
  article-title: COVID-19 and the role of cytokines in this disease
  publication-title: Inflammopharmacology
  doi: 10.1007/s10787-022-00992-2
– volume: 26
  year: 2020
  ident: B61
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0901-9
– volume: 370
  year: 2020
  ident: B31
  article-title: Autoantibodies against type I IFNs in patients with life-threatening COVID-19
  publication-title: Science
  doi: 10.1126/science.abd4585
– volume: 9
  year: 2020
  ident: B64
  article-title: Neutrophil extracellular traps (NETs) take the central stage in driving autoimmune responses
  publication-title: Cells
  doi: 10.3390/cells9040915
– volume: 3
  year: 2021
  ident: B24
  article-title: Epstein Barr Virus and autoimmune responses in systemic lupus erythematosus
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.623944
– volume: 7
  year: 2021
  ident: B50
  article-title: PD-L1 dysregulation in COVID-19 patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.695242
– volume: 466
  year: 2010
  ident: B15
  article-title: An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
  publication-title: Nature
  doi: 10.1038/nature09247
– volume: 47
  year: 2019
  ident: B20
  article-title: NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz240
– volume: 12
  start-page: R53
  year: 2010
  ident: B71
  article-title: Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2964
– volume: 12
  year: 2016
  ident: B30
  article-title: New insights into the immunopathogenesis of systemic lupus erythematosus
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2016.186
– volume: 47
  start-page: 395
  year: 2021
  ident: B69
  article-title: B cells in systemic lupus erythematosus: from disease mechanisms to targeted therapies
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2021.04.006
– volume: 80
  start-page: 895
  year: 2021
  ident: B39
  article-title: POS1223 RAS GUANYL RELEASING PROTEIN 1 (RASGRP1) IN PERIPHERAL b CELLS LINKS RA TO COVID-19
  publication-title: Ann Rheumatic Dis
  doi: 10.1136/annrheumdis-2021-eular.2809
– volume: 16
  start-page: 19
  year: 2020
  ident: B6
  article-title: Immunological pathogenesis and treatment of systemic lupus erythematosus
  publication-title: World J Pediatr
  doi: 10.1007/s12519-019-00229-3
– volume: 39
  year: 2020
  ident: B9
  article-title: Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-020-05073-9
– volume: 45
  year: 2016
  ident: B36
  article-title: CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.06.028
– volume: 218
  year: 2020
  ident: B43
  article-title: Long-term infection of SARS-CoV-2 changed the body’s immune status
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2020.108524
– volume: 11
  year: 2019
  ident: B48
  article-title: PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aax1159
– volume: 1982
  year: 2019
  ident: B63
  article-title: Neutrophil extracellular traps
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-9424-3_31
– volume: 39
  year: 2020
  ident: B11
  article-title: Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-020-05301-2
– volume: 40
  year: 2001
  ident: B25
  article-title: Retroviruses and autoimmunity
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.40.80
– volume: 47
  start-page: 1452
  year: 2020
  ident: B26
  article-title: The plight of patients with lupus nephritis during the outbreak of COVID-19 in wuhan, China
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.200452
– volume: 17
  year: 2022
  ident: B49
  article-title: Role of the PD-1 and PD-L1 axis in COVID-19
  publication-title: Future Microbiol
  doi: 10.2217/fmb-2022-0103
– volume: 18
  start-page: 9
  year: 2009
  ident: B45
  article-title: Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis
  publication-title: Lupus
  doi: 10.1177/0961203308093923
– volume: 175
  start-page: 159
  year: 2018
  ident: B21
  article-title: Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2018.08.065
– volume: 187
  year: 2011
  ident: B68
  article-title: Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100450
– volume: 12
  year: 2021
  ident: B44
  article-title: A snapshot of the PD-1/PD-L1 pathway
  publication-title: J Cancer
  doi: 10.7150/jca.57334
– volume: 12
  year: 2022
  ident: B70
  article-title: Innate lymphoid cells in autoimmune diseases
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.789788
– volume: 29
  year: 2013
  ident: B17
  article-title: Cytoscape app store
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt138
– volume: 23
  start-page: 596
  year: 2014
  ident: B22
  article-title: Viruses as potential pathogenic agents in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203314531637
– volume: 25
  year: 2009
  ident: B16
  article-title: Complex discovery from weighted PPI networks
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp311
– volume: 10
  year: 2013
  ident: B72
  article-title: DGIdb: mining the druggable genome
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2689
– volume: 5
  year: 2020
  ident: B65
  article-title: Neutrophil extracellular traps in COVID-19
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.138999
– volume: 125
  year: 2021
  ident: B28
  article-title: Short term outcomes of COVID-19 in lupus: propensity score matched analysis from a nationwide multi-centric research network
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2021.102730
– volume: 97
  start-page: 1
  year: 2019
  ident: B46
  article-title: PD-1 immunobiology in systemic lupus erythematosus
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2018.10.025
– volume: 31
  year: 2020
  ident: B13
  article-title: Kidney biopsy findings in patients with COVID-19
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2020060802
SSID ssj0000493335
Score 2.3654134
Snippet Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus...
ObjectiveEvidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1179664
SubjectTerms bioinformatics
COVID-19
diagnostic biomarkers
immune cells infiltration
Immunology
system lupus erythematosus
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQUiUuiLY8wqNyJW4okNhxHB9h6YpWanthETfLcRxYtJusdjeH_Rv9xczE2dVuVdELx7wtz9jzffbkG0LOY9wXhAEdFsKxMCkjFeJSQ5gaJvLYFY61WzE_f6V3g-THo3hcK_WFOWFeHth33JXC0hCyFDZFcTsXqcJkFjhMVkaSFapl65GK1sjUi8e9nHPh_5IBFqauyuF43FxisXDcpwSQn2xEolaw_18o8-9kybXo098jux1spNe-uR_Jlqs-kQ--kOTiM_mzSqWjAOjopJ5jEhA8AP4EfkZhcqkx5wUINsUaxPUTTnHDGa1L6rWc6aiZNDPqpgsv41rP4AgXaWnv98P32zBWFANeQeFtmIY-dc8-9Z3mw7pTX0XFZ2o6lZN9Muh_u-_dhV21hdACRZ6DsYw0zikY0LFhWWQNz2GqBGPZyEIYV8IwYGM2i20iEpYYaQspHOeqZJF0MT8g21VduSNCc5maNOOFAq6VWJHlFqIeL3J4dwoATQYkXva8tp0UOVbEGGmgJGgt3VpLo7V0Z62AXKyemXghjjfvvkGDru5EEe32BLiW7lxL_8-1AvJ16Q4aBh3upJjK1c1MAyZLGRBdmQXk0LvH6lNcIuhJWECyDcfZaMvmlWr43Ap7o7ihgCn3-D1af0J2sEcwrY2xU7I9nzbuDADUPP_SjpVXTOIaEg
  priority: 102
  providerName: Directory of Open Access Journals
Title Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/37426642
https://www.proquest.com/docview/2836291778
https://pubmed.ncbi.nlm.nih.gov/PMC10325730
https://doaj.org/article/980817f5c60249e09da8c4468f072d90
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELbGEBIviN8EtslIvKGMxHbi-AGhbTAG0uCFor5ZjuNsRV1ckkai_wZ_MXeJW1E0EC-V2jo_mrvzfZ99_Y6QFynuC0JAx1XmWCzqRMW41BDnhmVl6irHhq2Y80_52UR8nGbTHbJudxQeYHcttcN-UpN2fvjj--oNBPxrZJyQb1_Vs6ur_hD7gOMWJOB3cYPchMyUIxk7D3D_24iGOR96bqYwKAZfFuP_aP5ymq1cNUj6X4dD_yyn_C0_nd4ldwKwpEejJ9wjO665T26NrSZXD8jPTbEdBchHF36JZUJwAHgceCKF6cdjVQxQcIpdiv0FToKzjvqajmrPdN4v-o66djUKvfoO3uEyLj35_PXD2zhVFFNiReFsWKjeusuxOJ6WMx_0WVETmpqgg_KQTE7ffTk5i0M_htgCiV6COY00zikI-dSwIrGGlzCZgjltYiHRq8ww4Gu2SK3IBBNG2kpmjnNVs0S6lD8iu41v3BNCS5mbvOCVAjYmbFaUFvIir0o4dw4QTkYkXT95bYNYOfbMmGsgLWgtPVhLo7V0sFZEXm6OWYxSHf8cfYwG3YxEme3hA99e6BC1WmFfEllnNkdlRZeoyhQWCHRRJ5JVKonI87U7aAhL3GsxjfN9pwG15QyosCwi8nh0j82luERYJFhEii3H2bqX7W-a2eUg_Y3yhxlMyk__48LPyG38wVjXxtge2V22vdsHBLUsD4aVB3h9P00PhhD5BXlsHM0
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+potential+common+denominator+pathogenesis+of+system+lupus+erythematosus+with+COVID-19+based+on+comprehensive+bioinformatics+analysis&rft.jtitle=Frontiers+in+immunology&rft.au=Zeng%2C+Huiqiong&rft.au=Zhuang%2C+Yu&rft.au=Li%2C+Xiaojuan&rft.au=Yin%2C+Zhihua&rft.date=2023-06-22&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=14&rft.spage=1179664&rft_id=info:doi/10.3389%2Ffimmu.2023.1179664&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon